APTOSE BIOSCIENCES INC (APS.CA) Stock Analyst Earnings Estimates
TSX:APS - Toronto Stock Exchange - CA03835T4081 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 80.52% | N/A 44.11% | N/A 37.01% | |||||||||||
| EBITDA YoY % growth | -8.654M | -12.782M -47.70% | -14.157M -10.76% | -11.742M 17.06% | -29.02M -147.15% | -26.705M 7.98% | -55.616M -108.26% | -65.297M -17.41% | -42.482M 34.94% | -52.268M -23.04% | N/A 38.92% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.674M | -12.857M -48.23% | -14.273M -11.01% | -11.826M 17.14% | -29.107M -146.13% | -26.857M 7.73% | -55.768M -107.65% | -65.447M -17.36% | -42.602M 34.91% | -52.356M -22.90% | N/A 41.13% | N/A 0.74% | N/A 17.99% | N/A 167.04% | N/A 537.81% | N/A 110.72% | N/A 59.03% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -431.36 -60.44% | -503.19 -16.65% | N/A 20.46% | -377.99 5.57% | -234.00 38.09% | -301.50 -28.85% | -328.50 -8.96% | -202.50 38.36% | -231.60 -14.37% | -47.24 79.60% | N/A 95.27% | N/A 20.09% | N/A 125.51% | N/A 478.31% | N/A 105.75% | N/A 52.70% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.54 88.40% | -2.50 80.63% | -0.81 92.74% | -0.91 32.10% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -7.14M 26.72% | -7.344M -0.31% | N/A | N/A |
| EBIT Q2Q % growth | -5.911M 39.44% | -6.217M 15.36% | -13.005M -86.72% | -14.79M -137.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -1.34 96.91% | -10.71 | 9.37 | 87.52% |
| Q3 2024 Q2Q % growth | -11.10 78.98% | -36.41 | 25.31 | 69.52% |
| Q2 2024 Q2Q % growth | -12.90 81.06% | -36.11 | 23.21 | 64.27% |
| Q1 2024 Q2Q % growth | -21.90 67.56% | -22.64 | 0.74 | 3.29% |
| Q4 2023 Q2Q % growth | -43.20 12.73% | -48.81 | 5.61 | 11.49% |
| Q3 2023 Q2Q % growth | -52.80 -6.67% | -62.86 | 10.06 | 16.01% |
| Q2 2023 Q2Q % growth | -68.10 -37.58% | -61.64 | -6.46 | -10.49% |
| Q1 2023 Q2Q % growth | -67.50 -25.00% | -53.55 | -13.95 | -26.05% |
| Q4 2022 Q2Q % growth | -49.50 59.26% | -49.83 | 0.33 | 0.67% |
| Q3 2022 Q2Q % growth | -49.50 15.38% | -55.74 | 6.24 | 11.19% |
| Q2 2022 Q2Q % growth | -49.50 26.67% | -61.64 | 12.14 | 19.69% |
| Q1 2022 Q2Q % growth | -54.00 33.33% | -71.15 | 17.14 | 24.10% |
| Q4 2021 Q2Q % growth | -121.50 -68.75% | -78.69 | -42.81 | -54.41% |
| Q3 2021 Q2Q % growth | -58.50 13.33% | -76.72 | 18.22 | 23.75% |
| Q2 2021 Q2Q % growth | -67.50 28.57% | -85.49 | 17.99 | 21.04% |
| Q1 2021 Q2Q % growth | -81.00 -20.00% | -78.60 | -2.40 | -3.05% |
| Q4 2020 Q2Q % growth | -72.00 -23.08% | -77.46 | 5.46 | 7.04% |
| Q3 2020 Q2Q % growth | -67.50 -25.00% | -79.75 | 12.25 | 15.36% |
| Q2 2020 Q2Q % growth | -94.50 -61.54% | -66.88 | -27.62 | -41.30% |
| Q1 2020 Q2Q % growth | -67.50 -7.14% | -48.20 | -19.31 | -40.06% |
| Q4 2019 Q2Q % growth | -58.50 | -56.39 | -2.11 | -3.74% |
| Q3 2019 Q2Q % growth | -54.00 | -61.63 | 7.63 | 12.38% |
| Q2 2019 Q2Q % growth | -58.50 | -67.40 | 8.90 | 13.21% |
| Q1 2019 Q2Q % growth | -63.00 | -78.55 | 15.55 | 19.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |